Human Rotator Cuff Tears Reveal an Age‐Dependent Increase in Markers of Cellular Senescence and Selective Removal of Senescent Cells With Dasatinib + Quercetin Increases Genetic Expression of COL1A1 In Vitro

Authors:

Abstract
Purpose: To quantify cellular senescence in supraspinatus tendon and subacromial bursa of humans with rotator cuff tears and to investigate the in vitro efficacy of the senolytic dasatinib + quercetin (D+Q) to eliminate senescent cells and alter tenogenic differentiation. Methods: Tissue was harvested from 41 patients (mean age, 62 years) undergoing arthroscopic rotator cuff repairs. In part 1 (n = 35), senescence was quantified using immunohistochemistry and gene expression for senescent cell markers (p16 and p21) and the senescence‐associated secretory phenotype (SASP) (interleukin [IL] 6, IL‐8, matrix metalloproteinase [MMP] 3, monocyte chemoattractant protein [MCP] 1). Senescence was compared between patients P < .05). A significant increase was seen in immunohistochemical staining of bursa p21 ( P = .028). In part 2, D+Q significantly decreased expression of p21, IL‐6, and IL‐8 in tendon and p21 and IL‐8 in bursa ( P < .05). Enzyme‐linked immunosorbent assay analysis showed decreased release of the SASP (IL‐6, MMP‐3, MCP‐1; P = .002, P = .024, P < .001, respectively). Tendon ( P = .022) and bursa ( P = .027) treated with D+Q increased the expression of COL1A1. Conclusions: While there was an age‐dependent increase in markers of cellular senescence, this relationship was not consistently seen across all markers and tissues. Dasatinib + quercetin had moderate efficacy in decreasing senescence in these tissues and increasing COL1A1 expression. Clinical Relevance: This study reveals that cellular senescence may be a therapeutic target to alter the biological aging of rotator cuffs and identifies D+Q as a potential therapy.
Funding Information
  • Arthroscopy Association of North America
  • University of Connecticut (07-224-02)

This publication has 48 references indexed in Scilit: